Innovative CRISPR Advancements: The PASTE Technique Explained
Written on
Chapter 1: Understanding CRISPR Technology
CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, has transformed genetic engineering by enabling precise modifications to DNA. This innovative tool has found applications across various fields, including biomedical research, agriculture, and environmental science. Utilizing an enzyme known as Cas9 (CRISPR-associated protein 9), CRISPR cuts DNA at specific locations, allowing the cell's natural repair mechanisms to modify the genetic material during the repair process.
Since its inception, CRISPR has evolved significantly. Initially, it was limited to minor DNA alterations, but advancements have led to versions that facilitate more accurate and efficient edits. For instance, recent iterations can target multiple genomic sites simultaneously and modify RNA instead of just DNA.
Section 1.1: The Emergence of PASTE
In recent developments, researchers from MIT have introduced an additional sophisticated method to the CRISPR toolkit, referred to as ‘PASTE.’ This novel technique shows promise for addressing diseases linked to numerous mutations.
The PASTE system has demonstrated the capability of delivering genes as extensive as 36,000 DNA base pairs into various human cell types. It merges the precise targeting abilities of CRISPR-Cas9 with integrases—enzymes initially derived from bacterial defense systems. These integrases, used by viruses to incorporate their genetic material into bacterial genomes, aim to overcome challenges posed by traditional CRISPR methods.
Section 1.2: Addressing Limitations in Gene Editing
The MIT research team sought to tackle existing CRISPR limitations, such as the creation of double-stranded DNA breaks and the dependency on dividing cells for effectiveness. Such breaks can lead to harmful chromosomal alterations. To address this, they utilized integrases, a family of enzymes that bacteriophages employ to insert themselves into bacterial DNA.
“It’s a new genetic way of potentially targeting these really hard-to-treat diseases. We wanted to work toward what gene therapy was supposed to do at its original inception, which is to replace genes, not just correct individual mutations,” remarked Omar Abudayyeh, the study's senior author.
Chapter 2: The Mechanism of PASTE
The researchers focused on serine integrases, which can incorporate large DNA segments (up to 50,000 base pairs) into designated genomic sequences known as attachment sites or “landing pads.” These sites facilitate the binding of integrases, which subsequently integrate their DNA payloads.
The PASTE tool employs a Cas9 enzyme that targets specific genomic sites, guided by a strand of RNA. By inserting a 46-base pair landing site without creating double-stranded breaks, PASTE first adds one DNA strand via a fused reverse transcriptase before introducing the complementary strand.
The trials indicated that PASTE could insert genes into various human cells, including liver cells, T cells, and lymphoblasts (immature white blood cells). The delivery system was tested with 13 different payload genes, successfully integrating them into nine genomic locations. The insertion success rates ranged between 5 to 60 percent, with minimal unwanted insertions or deletions at the integration sites.
The researchers also illustrated PASTE's ability to insert genes into "humanized" livers of mice, achieving successful integration in about 2.5 percent of human hepatocytes present. While the study involved DNA sequences up to 36,000 base pairs, there is potential for using even longer sequences.
Section 2.1: Future Applications of PASTE
The researchers are exploring the potential of PASTE for replacing defective genes responsible for conditions like cystic fibrosis. Additionally, this technique could be beneficial in treating blood disorders stemming from genetic defects, such as hemophilia and G6PD deficiency, as well as neurological disorders like Huntington’s disease, caused by genes with excessive repeats. The genetic constructs developed in this study are available for other researchers to utilize online.
The complete findings were published in the Journal of Nature Biotechnology.
Stay updated with the latest stories and insights by following Faisal Khan on Medium and subscribing to my weekly newsletter.